BACKGROUND: Several studies have shown linkage of chromosome 12q 13-24 with atopy related phenotypes. Among candidate genes in this region is STAT6 (signal transducer and activator of transcription), which is essential for Th2 cell differentiation, recruitment, and effector function. METHODS: We evaluated six polymorphisms of STAT6 for evidence of associations with serum IgE levels and atopic diseases in a population based cross sectional cohort of 1407 German adults. Genotyping was performed using the matrix assisted laser desorption ionisation-time of flight mass spectrometry method. Haplotypes were estimated using the SAS/Genetics module, and population-derived IgE percentiles (50% IgE>53 kU/l, 66% IgE>99 kU/l and 90% IgE>307 kU/l) were modelled as outcome variables in haplotype trend regression analysis. RESULTS: All polymorphisms were genotyped successfully. Haplotype reconstruction revealed 8/64 possible haplotypes, reaching estimated frequencies of 1% or more. One polymorphism in intron 2 (rs324011) showed a significant association with total serum IgE (p = 0.015). A STAT6 risk haplotype for elevated IgE showing odds ratios of 1.7 (p = 0.015) for IgE cut-off 100 kU/l, and 1.54 (p = 0.032), 1.6 (p = 0.025), and 2.54 (p = 0.007) for IgE percentiles 50%, 66%, and 90%, respectively was detected. The increased risk of this haplotype was confirmed by linear haplotype trend regression on log transformed IgE values (p = 0.007). Analysis further revealed a risk haplotype for specific sensitisation and a risk haplotype for asthma. CONCLUSION: The data indicate that genetic variants within STAT6 contribute significantly to IgE regulation and manifestation of atopic diseases.
BACKGROUND: Several studies have shown linkage of chromosome 12q 13-24 with atopy related phenotypes. Among candidate genes in this region is STAT6 (signal transducer and activator of transcription), which is essential for Th2 cell differentiation, recruitment, and effector function. METHODS: We evaluated six polymorphisms of STAT6 for evidence of associations with serum IgE levels and atopic diseases in a population based cross sectional cohort of 1407 German adults. Genotyping was performed using the matrix assisted laser desorption ionisation-time of flight mass spectrometry method. Haplotypes were estimated using the SAS/Genetics module, and population-derived IgE percentiles (50% IgE>53 kU/l, 66% IgE>99 kU/l and 90% IgE>307 kU/l) were modelled as outcome variables in haplotype trend regression analysis. RESULTS: All polymorphisms were genotyped successfully. Haplotype reconstruction revealed 8/64 possible haplotypes, reaching estimated frequencies of 1% or more. One polymorphism in intron 2 (rs324011) showed a significant association with total serum IgE (p = 0.015). A STAT6 risk haplotype for elevated IgE showing odds ratios of 1.7 (p = 0.015) for IgE cut-off 100 kU/l, and 1.54 (p = 0.032), 1.6 (p = 0.025), and 2.54 (p = 0.007) for IgE percentiles 50%, 66%, and 90%, respectively was detected. The increased risk of this haplotype was confirmed by linear haplotype trend regression on log transformed IgE values (p = 0.007). Analysis further revealed a risk haplotype for specific sensitisation and a risk haplotype for asthma. CONCLUSION: The data indicate that genetic variants within STAT6 contribute significantly to IgE regulation and manifestation of atopic diseases.
Authors: R Nickel; U Wahn; N Hizawa; N Maestri; D L Duffy; K C Barnes; K Beyer; J Forster; R Bergmann; F Zepp; V Wahn; D G Marsh Journal: Genomics Date: 1997-11-15 Impact factor: 5.736
Authors: Michael D Howell; Peisong Gao; Byung Eui Kim; Leighann J Lesley; Joanne E Streib; Patricia A Taylor; Daniel J Zaccaro; Mark Boguniewicz; Lisa A Beck; Jon M Hanifin; Lynda C Schneider; Tissa R Hata; Richard L Gallo; Mark H Kaplan; Kathleen C Barnes; Donald Y M Leung Journal: J Allergy Clin Immunol Date: 2011-07-18 Impact factor: 10.793
Authors: Steve D Swain; Nicole N Meissner; Dan W Siemsen; Kate McInnerney; Allen G Harmsen Journal: Am J Respir Cell Mol Biol Date: 2011-09-29 Impact factor: 6.914
Authors: Justin Mostecki; Suzanne L Cassel; Walter T Klimecki; Debra A Stern; Judit Knisz; Sachiyo Iwashita; Penelope Graves; Rachel L Miller; Maartje van Peer; Marilyn Halonen; Fernando D Martinez; Donata Vercelli; Paul B Rothman Journal: J Immunol Date: 2011-07-27 Impact factor: 5.422
Authors: C Herder; N Klopp; J Baumert; M Müller; N Khuseyinova; C Meisinger; S Martin; T Illig; W Koenig; B Thorand Journal: Diabetologia Date: 2007-08-22 Impact factor: 10.122
Authors: Mark Granada; Jemma B Wilk; Marina Tuzova; David P Strachan; Stephan Weidinger; Eva Albrecht; Christian Gieger; Joachim Heinrich; Blanca E Himes; Gary M Hunninghake; Juan C Celedón; Scott T Weiss; William W Cruikshank; Lindsay A Farrer; David M Center; George T O'Connor Journal: J Allergy Clin Immunol Date: 2011-11-09 Impact factor: 10.793